| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |